Immediate Impact
8 from Science/Nature 70 standout
Citing Papers
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Works of David Stroncek being referenced
Long-Term Outcomes Following CD19 CAR T Cell Therapy for B-ALL Are Superior in Patients Receiving a Fludarabine/Cyclophosphamide Preparative Regimen and Post-CAR Hematopoietic Stem Cell Transplantation
2016
T Cells Expressing a Novel Fully-Human Anti-CD19 Chimeric Antigen Receptor Induce Remissions of Advanced Lymphoma in a First-in-Humans Clinical Trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| David Stroncek | 230 | 45 | 109 | 150 | 112 | 18 | 452 | |
| Pilvi Maliniemi | 259 | 10 | 138 | 237 | 87 | 16 | 487 | |
| Ivana Heřmanová | 95 | 49 | 129 | 191 | 35 | 15 | 393 | |
| Dinithi Senadheera | 55 | 14 | 22 | 264 | 63 | 17 | 411 | |
| Tatiana Gorletta | 31 | 32 | 110 | 287 | 35 | 12 | 460 | |
| Claudia C. Bippes | 283 | 3 | 175 | 152 | 59 | 13 | 439 | |
| Atsushi Okuma | 167 | 26 | 183 | 126 | 53 | 11 | 420 | |
| John D. Jeppson | 168 | 4 | 283 | 118 | 70 | 16 | 469 | |
| W. Tristram Arscott | 174 | 21 | 48 | 275 | 36 | 20 | 506 | |
| Kazuo Nagashima | 161 | 16 | 19 | 164 | 16 | 17 | 434 | |
| Anna Brandt | 233 | 60 | 105 | 133 | 55 | 15 | 453 |
All Works
Loading papers...